Sponsor Check › Person
Named as an officer, director or promoter on SEC Form D filings · CA, WA, PA · Dec 8, 2008 → Feb 17, 2026
Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:17 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET
Jeff Himawan is listed as an executive officer, director, and promoter on 25 SEC Form D filings by 6 issuers between Dec 2008 and Aug 2026. Largest by amount reported sold: HORIZON PHARMA, INC. (Deerfield, IL — pharmaceuticals — 2010–2013; $150M reported sold to 74 investors), CATALYST BIOSCIENCES INC (South San Fransicso, CA — biotechnology — 2008–2015; $40.4M reported sold to 21 investors), Light Sciences Oncology Inc (Bellevue, WA — biotechnology — 2011–2013; $35.1M reported sold to 17 investors), HORIZON THERAPEUTICS INC (Northbrook, IL — pharmaceuticals — 2009–2010; $17M reported sold to 26 investors), NeXeption Capital Fund I, L.P. (Chester Springs, PA — pooled investment fund — 2026; $12.6M reported sold to 31 investors) and 1 more (all listed below).
What this means A repeat sponsor — 6 separate companies raised money with this person listed as executive officer, director, and promoter, over about 18 years. Across those companies the filings report $264.7M sold in total.
Listed alongside Jeffrey W. Bird (11 shared filings), Timothy P. Walbert (11 shared filings), Louis C. Bock (10 shared filings), Jean-Francois Formela (8 shared filings), Robert De Vaere (8 shared filings) and 41 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Jeff. Each name links to their own page.
2 of the issuers belong to the sponsor group Nexeos (2 issuers, $15.6M reported sold, 2019–2026).
What this means A sponsor group is one team that sets up a new company for each deal. Nexeos has 2 companies on file and $15.6M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 25 public filings for Jeff Himawan and found 7 differences, 2 worth asking the sponsor about: Amount sold went down between filings; 6 Form Ds were filed more than 15 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.
Community search for Jeff Himawan has not run yet — it is joining a line of 24,584 names; searches run around the clock at the hosts' allowed rate. Searched so far: 638 names.
Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).
Five things investors ask first. Items still in human review are counted, not shown.
None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026
Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:17 AM ET.
State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: VA (crawled Oct 23, 2026)
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Jeff Himawan..
State securities regulators: Securities regulators searched (3,318 actions): AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE DOJ Investor Protection Unit (257 actions, 1987–2026), TX State Securities Board (586 actions, 2006–2026), WA DFI (2,039 actions, 2001–2026) — last crawled Oct 23, 2026, 9:57 PM ET. No machine-readable public listing today for CO, FL, IA, IN, MN, NE, NJ, NY, OH, UT, VA (see docs/state-regulators.md).
None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026
Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:17 AM ET.
State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
Comparisons cover issuers and sponsor groups — see the issuer pages under Deals
7 differences found between the filings for Jeff Himawan — 2 worth asking about (compared 25 filings on Oct 24, 2026)
United States Bankruptcy Court, E.D. Pennsylvania docket "Louis R. Manzi" filed May 28, 1993, closed Apr 20, 1994. Louis Manzi (listed on the same filings) is listed as Debtor ("Louis R. Manzi"). Our match estimate: 70%.
What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.
The Mar 16, 2010 filing says $17,000,000 sold; the Mar 17, 2010 Form D says $8,000,235 sold — $8,999,765 less.
What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.
Form D filed 100 days after the first sale — HORIZON THERAPEUTICS INC · Form D filed 17 days after the first sale — NeXeption Capital Fund I, L.P. · Form D filed 17 days after the first sale — HORIZON PHARMA, INC. · Form D filed 17 days after the first sale — HORIZON PHARMA, INC. · Form D filed 53 days after the first sale — HORIZON PHARMA, INC. · and 1 more
What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.
No amendment in the last 12 months on an offering that may still be open — CATALYST BIOSCIENCES INC (latest filing Jul 13, 2015) · No amendment in the last 12 months on an offering that may still be open — CATALYST BIOSCIENCES INC (latest filing Feb 3, 2015) · No amendment in the last 12 months on an offering that may still be open — CATALYST BIOSCIENCES INC (latest filing Aug 20, 2013) · No amendment in the last 12 months on an offering that may still be open — CATALYST BIOSCIENCES INC (latest filing Sep 25, 2012) · No amendment in the last 12 months on an offering that may still be open — HORIZON PHARMA, INC. (latest filing May 4, 2011) · and 2 more
What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.
Offering amount changed between filings — CATALYST BIOSCIENCES INC · Offering amount changed between filings — HORIZON PHARMA, INC. · Offering amount changed between filings — HORIZON PHARMA, INC. · Offering amount lowered between filings — HORIZON THERAPEUTICS INC · Offering amount changed between filings — HORIZON THERAPEUTICS INC
What this means Targets change as deals grow or shrink. Ask whether later money has the same terms.
The people listed on the Jun 17, 2011 filing give Northbrook, IL; on the Mar 8, 2012 filing they give Deerfield, IL. The address now on file (520 Lake Cook Road, Suite 520, Deerfield, IL) is a registered-agent or shared-office address used by 6 issuers.
What this means A registered agent's address is a mailbox, not where the team works. Ask where the business actually operates.
CA on 21 filings (Dec 8, 2008 to Feb 17, 2026); WA on 3 filings (Jun 10, 2011 to Dec 23, 2013); PA on 1 filing (Aug 17, 2026).
What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.
What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.
4 of 20 offerings report sales commissions totalling $12,532,200; 0 report finder's fees; 1 reports proceeds to related persons totalling $300,000. (includes amounts the issuer reported as estimates)
| Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it | Source |
|---|---|---|---|---|---|
| Aug 17, 2026 D NeXeption Capital Fund I, L.P. File 021-594411 | $0 | $0 | $0 (est.) An affiliate of the General Partner will be receiving a management fee and the General Partner will be receiving a carried interest. All or most of the proceeds are expected to be invested in affiliates of the persons named in item 3 | None listed on this filing | EDGAR ↗ |
| Feb 17, 2026 D NexEos Diagnostics, Inc. File 021-573648 | $0 | $0 | $0 (est.) | None listed on this filing | EDGAR ↗ |
| Jun 6, 2024 D NexEos Diagnostics, Inc. File 021-515331 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Feb 15, 2023 D NexEos Diagnostics, Inc. File 021-473497 | $0 | $0 | $300,000 (est.) | None listed on this filing | EDGAR ↗ |
| Jul 13, 2015 D/A CATALYST BIOSCIENCES INC File 021-241558 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Feb 3, 2015 D CATALYST BIOSCIENCES INC File 021-233381 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Apr 23, 2014 D CATALYST BIOSCIENCES INC File 021-216115 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Dec 23, 2013 D Light Sciences Oncology Inc File 021-208551 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Dec 9, 2013 D HORIZON PHARMA, INC. File 021-207631 | $6,000,000 | $0 | $0 | JMP Securities LLC BrokerCheck CRD 22208 ↗ via JMP Securities LLC (CRD 22208 ↗) Cowen and Company, LLC BrokerCheck CRD 7616 ↗ via Cowen and Company, LLC (CRD 7616 ↗) | EDGAR ↗ |
| Aug 20, 2013 D CATALYST BIOSCIENCES INC File 021-201639 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Sep 25, 2012 D CATALYST BIOSCIENCES INC File 021-184613 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Mar 19, 2012 D HORIZON PHARMA, INC. File 021-175137 | $3,124,200 | $0 | $0 | JMP Securities, LLC BrokerCheck CRD 22208 ↗ via JMP Securities, LLC (CRD 22208 ↗) Cowen & Company LLC BrokerCheck CRD 7616 ↗ via Cowen & Company LLC (CRD 7616 ↗) Stifel, Nicolaus & Company Incorporated BrokerCheck CRD 793 ↗ via Stifel, Nicolaus & Company Incorporated (CRD 793 ↗) | EDGAR ↗ |
| Mar 8, 2012 D HORIZON PHARMA, INC. File 021-174559 | $3,000,000 | $0 | $0 | JMP Securities, LLC BrokerCheck CRD 22208 ↗ via JMP Securities, LLC (CRD 22208 ↗) Cowen & Company LLC BrokerCheck CRD 7616 ↗ via Cowen & Company LLC (CRD 7616 ↗) Stifel, Nicolaus & Company Incorporated BrokerCheck CRD 793 ↗ via Stifel, Nicolaus & Company Incorporated (CRD 793 ↗) | EDGAR ↗ |
| Jan 23, 2012 D Light Sciences Oncology Inc File 021-172323 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jun 17, 2011 D HORIZON PHARMA, INC. File 021-161427 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jun 10, 2011 D Light Sciences Oncology Inc File 021-161122 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| May 4, 2011 D/A HORIZON PHARMA, INC. File 021-142454 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| May 24, 2010 D HORIZON PHARMA, INC. File 021-142452 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Mar 17, 2010 D HORIZON THERAPEUTICS INC File 021-125618 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Dec 8, 2008 D CATALYST BIOSCIENCES INC File 021-60286 | $408,000 | $0 | $0 | Seaview Securities LLC BrokerCheck CRD 126180 ↗ | EDGAR ↗ |
Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across every filing this person is listed on (latest filing per offering, per issuer).
Every issuer that named Jeff Himawan on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.
Raised $12.6M from 31 investors (50% of the $25M target) as of the latest filing. Jeff is listed as executive officer, promoter.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $9.68M from 22 investors (100% of the $3M target) as of the latest filing. Jeff is listed as director on 3 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $40.4M from 21 investors (100% of the $2M target) as of the latest filing. Jeff is listed as director on 7 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $35.1M from 17 investors (100% of the $350K target) as of the latest filing. Jeff is listed as director on 3 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $150M from 74 investors (100% of the $150M target) as of the latest filing. Jeff is listed as director on 8 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $17M from 26 investors (100% of the $9M target) as of the latest filing. Jeff is listed as director on 3 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.
Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.
Listed on the same filings as Jeff Himawan. Their page shows their other deals.
Jeffrey W. Bird is on 11 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Jeff Himawan. Their page shows their other deals.
Louis C. Bock is on 9 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Jeff Himawan. Their page shows their other deals.
Listed on the same filings as Jeff Himawan. Their page shows their other deals.
Asish Xavier is on 22 issuers in total — a repeat sponsor. Their page lists every one.
Ralph Christoffersen is on 7 issuers in total — a repeat sponsor. Their page lists every one.
Augustine Lawlor is on 16 issuers in total — a repeat sponsor. Their page lists every one.
Michael Powell is on 9 issuers in total — a repeat sponsor. Their page lists every one.
Stephen Tullman is on 11 issuers in total — a repeat sponsor. Their page lists every one.
Michael Grey is on 10 issuers in total — a repeat sponsor. Their page lists every one.
George F. Tidmarsh is on 5 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Jeff Himawan. Their page shows their other deals.
Listed on the same filings as Jeff Himawan. Their page shows their other deals.
Listed on the same filings as Jeff Himawan. Their page shows their other deals.
Listed on the same filings as Jeff Himawan. Their page shows their other deals.
Listed on the same filings as Jeff Himawan. Their page shows their other deals.
Listed on the same filings as Jeff Himawan. Their page shows their other deals.
Listed on the same filings as Jeff Himawan. Their page shows their other deals.
Peter Bisgaard is on 15 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Jeff Himawan. Their page shows their other deals.
Mitchell Hymowitz is on 6 issuers in total — a repeat sponsor. Their page lists every one.
One team, 2 deal companies. Jeff Himawan is listed on 2 of them.
Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Jeff Himawan.
A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.
None of the 6 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.
Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.
Property records are matched to companies only, never to individuals, so none are matched to Jeff Himawan by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 6 issuers this person is listed on — nothing matched.
Websites and social links of the issuers Jeff Himawan is listed on: none on file. No website or social profile named in CATALYST BIOSCIENCES INC's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #300,240 of 374,652 in line (1,245 issuers searched so far). One-tap searches: Look further ↓
One-tap searches on sites we do not index ourselves, with the name pre-filled (South San Fransicso, CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.
No corrections have been requested for this page.
Free. Logged with status: received → under review → fixed / confirmed with source.
If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.
Members get an email when Jeff Himawan appears on a new Form D, or when a court case or SEC action is matched to them. See plans →